Skip to content
November 8, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
Fueling the Future: HudsonAlpha Launches ‘The Primer Lab’ to Supercharge Alabama’s Biotech Ecosystem fueling-the-future-hudsonalpha-launches-the-primer-lab-to-supercharge-alabamas-biotech-ecosystem-7
  • Genomics and Precision Medicine

Fueling the Future: HudsonAlpha Launches ‘The Primer Lab’ to Supercharge Alabama’s Biotech Ecosystem

Nana October 21, 2026
HUNTSVILLE, Ala. — In a significant move to solidify Alabama’s status as a burgeoning titan of the...
Read More Read more about Fueling the Future: HudsonAlpha Launches ‘The Primer Lab’ to Supercharge Alabama’s Biotech Ecosystem
The Great Medicaid Retrenchment: How the 2025 Reconciliation Law is Reshaping American Healthcare the-great-medicaid-retrenchment-how-the-2025-reconciliation-law-is-reshaping-american-healthcare
  • Breast Cancer Legislation and Policy

The Great Medicaid Retrenchment: How the 2025 Reconciliation Law is Reshaping American Healthcare

Nila Kartika Wati October 21, 2026
The American social safety net is undergoing its most significant transformation in decades. As the federal government...
Read More Read more about The Great Medicaid Retrenchment: How the 2025 Reconciliation Law is Reshaping American Healthcare
The Intersection of GLP-1 Agonists and Breast Cancer: Navigating Emerging Data the-intersection-of-glp-1-agonists-and-breast-cancer-navigating-emerging-data
  • Survivorship and Post-Treatment

The Intersection of GLP-1 Agonists and Breast Cancer: Navigating Emerging Data

Reynand Wu October 21, 2026
By [Your Name/Editorial Staff], based on insights from the National Breast Cancer Foundation Disclaimer: The information provided...
Read More Read more about The Intersection of GLP-1 Agonists and Breast Cancer: Navigating Emerging Data
Breakthrough on the Horizon: Rapport Therapeutics’ RAP-219 Hits Key Milestone in Bipolar Mania Trial breakthrough-on-the-horizon-rapport-therapeutics-rap-219-hits-key-milestone-in-bipolar-mania-trial
  • Chemotherapy and Targeted Therapy

Breakthrough on the Horizon: Rapport Therapeutics’ RAP-219 Hits Key Milestone in Bipolar Mania Trial

Nana October 21, 2026
In a surprise development that has sent ripples of optimism through the biotechnology sector, Boston-based Rapport Therapeutics...
Read More Read more about Breakthrough on the Horizon: Rapport Therapeutics’ RAP-219 Hits Key Milestone in Bipolar Mania Trial
Navigating the Geopolitical Fault Lines: The WHO and the U.S. Withdrawal Crisis navigating-the-geopolitical-fault-lines-the-who-and-the-u-s-withdrawal-crisis-2
  • Global Breast Cancer Awareness

Navigating the Geopolitical Fault Lines: The WHO and the U.S. Withdrawal Crisis

Laily UPN October 21, 2026
The international health landscape faces a period of profound uncertainty as the World Health Organization (WHO) navigates...
Read More Read more about Navigating the Geopolitical Fault Lines: The WHO and the U.S. Withdrawal Crisis
Beyond the Stigma: Understanding and Confronting Male Breast Cancer in Canada beyond-the-stigma-understanding-and-confronting-male-breast-cancer-in-canada-6
  • Global Breast Cancer Awareness

Beyond the Stigma: Understanding and Confronting Male Breast Cancer in Canada

Siti Muinah October 21, 2026
To the general public, the diagnosis of breast cancer is almost exclusively associated with women. This societal...
Read More Read more about Beyond the Stigma: Understanding and Confronting Male Breast Cancer in Canada
Breakthrough in Breast Cancer Research: Unveiling a Novel Mechanism of Tumor Growth and Potential Therapeutic Targets breakthrough-in-breast-cancer-research-unveiling-a-novel-mechanism-of-tumor-growth-and-potential-therapeutic-targets
  • Medical Research and Clinical Trials

Breakthrough in Breast Cancer Research: Unveiling a Novel Mechanism of Tumor Growth and Potential Therapeutic Targets

Layla Zulfa October 21, 2026
Oklahoma City, OK – In a significant stride for cancer research, scientists at the University of Oklahoma...
Read More Read more about Breakthrough in Breast Cancer Research: Unveiling a Novel Mechanism of Tumor Growth and Potential Therapeutic Targets
ESMO26: HUTCHMED and AstraZeneca share positive outlook on NSCLC esmo26-hutchmed-and-astrazeneca-share-positive-outlook-on-nsclc
  • Medical Research and Clinical Trials

ESMO26: HUTCHMED and AstraZeneca share positive outlook on NSCLC

Nila Kartika Wati October 21, 2026
Here’s why: Insufficient Content for Expansion: The provided HTML snippet is a placeholder for premium content access....
Read More Read more about ESMO26: HUTCHMED and AstraZeneca share positive outlook on NSCLC
Navigating the Intersection: GLP-1 Medications and Breast Cancer – What the Science Says navigating-the-intersection-glp-1-medications-and-breast-cancer-what-the-science-says
  • Patient Advocacy and Support

Navigating the Intersection: GLP-1 Medications and Breast Cancer – What the Science Says

Layla Zulfa October 21, 2026
By Douglas Feil, NBCF Chief Program Officer In recent years, glucagon-like peptide-1 (GLP-1) receptor agonists have emerged...
Read More Read more about Navigating the Intersection: GLP-1 Medications and Breast Cancer – What the Science Says
Illuminating the Dark: Global #LightUpMBC Campaign to Spotlight Metastatic Breast Cancer Research and Resilience illuminating-the-dark-global-lightupmbc-campaign-to-spotlight-metastatic-breast-cancer-research-and-resilience
  • Patient Advocacy and Support

Illuminating the Dark: Global #LightUpMBC Campaign to Spotlight Metastatic Breast Cancer Research and Resilience

Basiran October 21, 2026
NEW YORK, NY — As the world enters the mid-point of Breast Cancer Awareness Month, a global...
Read More Read more about Illuminating the Dark: Global #LightUpMBC Campaign to Spotlight Metastatic Breast Cancer Research and Resilience

Posts pagination

Previous 1 … 71 72 73 74 75 76 77 … 869 Next

Recent Posts

  • Groundbreaking Discovery Sheds Light on Aggressive Breast Cancer’s Nerve Manipulation, Paving Way for Novel Therapies
  • Advocacy on the Hill: METAvivor’s Stage IV Stampede Mobilizes National Support for Metastatic Breast Cancer Research
  • The Silent Metric: How Patient-Reported Outcomes are Redefining the Standard of Care in Breast Cancer
  • Navigating the Orphan Frontier: FDA Launches Ambitious "Rare Disease Framework Initiative"
  • A New Dawn for Reproductive Medicine: The Breakthrough of Mitochondrial Donation

Recent Comments

No comments to show.

Archives

  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

groundbreaking-discovery-sheds-light-on-aggressive-breast-cancers-nerve-manipulation-paving-way-for-novel-therapies
  • Medical Research and Clinical Trials

Groundbreaking Discovery Sheds Light on Aggressive Breast Cancer’s Nerve Manipulation, Paving Way for Novel Therapies

Pevita Pearce November 7, 2026
advocacy-on-the-hill-metavivors-stage-iv-stampede-mobilizes-national-support-for-metastatic-breast-cancer-research
  • Patient Advocacy and Support

Advocacy on the Hill: METAvivor’s Stage IV Stampede Mobilizes National Support for Metastatic Breast Cancer Research

Pevita Pearce November 7, 2026
the-silent-metric-how-patient-reported-outcomes-are-redefining-the-standard-of-care-in-breast-cancer
  • Patient Advocacy and Support

The Silent Metric: How Patient-Reported Outcomes are Redefining the Standard of Care in Breast Cancer

Iffa Jayyana November 7, 2026
navigating-the-orphan-frontier-fda-launches-ambitious-rare-disease-framework-initiative
  • Treatment Innovations

Navigating the Orphan Frontier: FDA Launches Ambitious "Rare Disease Framework Initiative"

Siti Muinah November 7, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.